EPRX
Eupraxia·NASDAQ
--
--(--)
--
--(--)
EPRX fundamentals
Eupraxia (EPRX) released its earnings on Nov 4, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.1927 (YoY -54.78%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.1927
-54.78%
Report date
Nov 4, 2025
EPS
Actual | -0.1242 | -0.1245 | -0.1816 | -0.2445 | -0.1927 |
Forecast | -0.1694 | -0.1307 | -0.1679 | -0.1882 | -0.1785 |
Surprise | +26.68% | +4.74% | -8.16% | -29.91% | -7.96% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is Eupraxia's gross profit margin?What does Eupraxia do and what are its main business segments?What guidance did Eupraxia's management provide for the next earnings period?What factors drove the changes in Eupraxia's revenue and profit?What is Eupraxia's latest dividend and current dividend yield?What were the key takeaways from Eupraxia's earnings call?Did Eupraxia beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Eupraxia year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
